FLGR-242

Key points

• FLGR-242 is sold as a research compound related to muscle growth, with little public scientific information.
• There is no body of published human research behind it.
• It has no UK marketing authorisation and is sold only for research use.
• Compounds of this kind, affecting muscle growth pathways, are generally prohibited in sport.

Quick facts

What it is

Experimental research compound (muscle area)

Evidence

Little or none published

UK status

Not a licensed medicine; sold for research use

In sport

Muscle growth agents are generally prohibited

How it works

The marketing places FLGR-242 in the muscle growth area, alongside compounds that act on pathways such as myostatin. Without published studies, how it is meant to work, and whether it does anything at all, cannot be stated with confidence.

What the evidence shows

There is little or no published evidence for FLGR-242 in people or animals. With no trials, no safety data and no established dose, there is no basis to judge whether it works or is safe.

What it does not settle

• There is essentially no published evidence of benefit or safety.
• There is no established dose.
• What is actually in products sold under this name is uncertain.

Side effects

Less common but serious

• With no safety data, the risks are simply unknown.
• Because there is no licensed product, the dose, purity and contents of material bought online cannot be verified.

Report any suspected side effect through the MHRA Yellow Card scheme.

UK legal status and access

FLGR-242 has no UK marketing authorisation, so it is not a licensed medicine and is not offered by registered clinics or pharmacies. It is sold online as a research chemical.

Common questions